Pharmaceutical Ingredients in Drinking Water: Overview of Occurrence and Significance of Human Exposure

被引:0
|
作者
Daughton, C. G. [1 ]
机构
[1] US EPA, Natl Exposure Res Lab, Las Vegas, NV 89119 USA
来源
CONTAMINANTS OF EMERGING CONCERN IN THE ENVIRONMENT: ECOLOGICAL AND HUMAN HEALTH CONSIDERATIONS | 2010年 / 1048卷
关键词
SOLID-PHASE EXTRACTION; PERSONAL CARE PRODUCTS; ENDOCRINE DISRUPTING COMPOUNDS; INDIRECT POTABLE REUSE; HEALTH-RISK ASSESSMENT; WASTE-WATER; LIQUID-CHROMATOGRAPHY; EMERGING CONTAMINANTS; MASS-SPECTROMETRY; GROUND-WATER;
D O I
暂无
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A comprehensive examination is presented of the data published through 2009 on the active pharmaceutical ingredients (APIs) that have been reported in finished drinking water (FDW). A synoptic review reveals that quantitative occurrence data for FDW exists for 64 APIs and miscellaneous transformation products, reported in 48 publications. Significantly, however, for these 64 substances only 17 have quantitative data from more than two reports each; only 36 have corroborative data from a second study. Almost all of the available data has been published since the year 2000. The occurrence data are organized around the Anatomical Therapeutic Chemical (ATC) classification system. The top four ATC classes for which the most API data have been reported are: N, C, V, and M. APIs have been reported for 7 of the 14 main ATC classes; no API has been reported for ATC classes A, B, H, L, R, or S. Some emphasis is also placed on negative data - those APIs with either data of absence or absence of data. The six most frequently reported APIs in FDW (in descending order) are: carbamazepine, ibuprofen, sulfamethoxazole, clofibric acid, gemfibrozil, and iopromide. The six APIs with roughly the most consistent highest reported concentrations are: ibuprofen, triclosan, carbamazepine, phenazone, clofibric acid, and acetaminophen. With only one exception (ibuprofen and its methyl ester metabolite), no API exceeded a concentration of 1 ppb (1 mu g/L). Also covered are some of the reported transformation products and disinfection by-products unique to APIs. Some of the less-discussed aspects of the potential ramifications for human health are also included. A clearer picture is emerging as to the extent and scope of API occurrence in drinking water, some preliminary generalizations can be drawn, and a better sense is emerging of where future research should be directed.
引用
收藏
页码:9 / 68
页数:60
相关论文
共 50 条
  • [21] Drinking water quality status in Malaysia: a scoping review of occurrence, human health exposure, and potential needs
    Praveena, Sarva Mangala
    Aris, Ahmad Zaharin
    Hashim, Zailina
    Hashim, Jamal Hisham
    JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY, 2024, 34 (01) : 161 - 174
  • [22] Drinking water quality status in Malaysia: a scoping review of occurrence, human health exposure, and potential needs
    Sarva Mangala Praveena
    Ahmad Zaharin Aris
    Zailina Hashim
    Jamal Hisham Hashim
    Journal of Exposure Science & Environmental Epidemiology, 2024, 34 : 161 - 174
  • [23] An Overview on Polymorph Preparation Methods of Active Pharmaceutical Ingredients
    Zhou, Yanan
    Lv, Changqi
    Liu, Xinman
    Gao, Jie
    Gao, Yun
    Wang, Ting
    Huang, Xin
    CRYSTAL GROWTH & DESIGN, 2023, 24 (01) : 584 - 600
  • [24] Occurrence and exposure risk evaluation of polyhalogenated carbazoles (PHCZs) in drinking water
    Wang, Guowei
    Jiang, Timing
    Li, Sen
    Hou, Huijie
    Xiao, Keke
    Hu, Jingping
    Liang, Sha
    Liu, Bingchuan
    Yang, Jiakuan
    SCIENCE OF THE TOTAL ENVIRONMENT, 2021, 750
  • [25] Drinking water exposure assessment for chlorpyrifos in North America: Overview and conclusions
    Bohaty, Rochelle
    Hetrick, James
    Spatz, Dana
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [26] Pharmaceutical compounds in drinking water
    Chander, Vikas
    Sharma, Bhavtosh
    Negi, Vipul
    Aswal, Ravinder Singh
    Singh, Prashant
    Singh, Rakesh
    Dobhal, Rajrendra
    JOURNAL OF XENOBIOTICS, 2016, 6 (01) : 1 - 7
  • [27] Pharmaceutical significance of Schiff bases: an overview
    Mushtaq, Irfan
    Ahmad, Maqbool
    Saleem, Muhammad
    Ahmed, Adnan
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 10 (01)
  • [28] Pharmaceutical significance of Schiff bases: an overview
    Irfan Mushtaq
    Maqbool Ahmad
    Muhammad Saleem
    Adnan Ahmed
    Future Journal of Pharmaceutical Sciences, 10
  • [29] Occurrence and seasonal variations of 25 pharmaceutical residues in wastewater and drinking water treatment plants
    A. Kot-Wasik
    A. Jakimska
    M. Śliwka-Kaszyńska
    Environmental Monitoring and Assessment, 2016, 188
  • [30] Occurrence of pharmaceutical residues in sewage, river, ground, and drinking water in Greece and Berlin (Germany)
    Heberer, Th.
    Fuhrmann, B.
    Schmidt-Baumler, K.
    Tsipi, D.
    Koutsouba, V.
    Hiskia, A.
    ACS Symposium Series, 2001, 791 : 70 - 83